BioMS Medical invests in Spectral Diagnostics securities

BioMS Medical Corp. (TSX: MS) acquired pursuant to a private placement of units, beneficial ownership and control over 30,000,000 common shares and 15,000,000 common shares purchase warrants of Spectral Diagnostics Inc. ("Spectral"). The 30,000,000 common shares represent 39.57% of the issued and outstanding common shares of Spectral and the warrants represent 61.5% of the warrants issued in the private placement. Assuming BioMS exercises the warrants and acquires an additional 15,000,000 common shares of Spectral, it would hold 45,000,000 common shares representing 49.55% of the partially diluted issued and outstanding common shares of Spectral. The units were acquired at a price of $0.40 per unit.

BioMS acquired the securities for investment purposes and has no present intention to acquire further securities of Spectral, although BioMS may in the future acquire or dispose of securities of Spectral, through the market, privately or otherwise, as circumstances or market conditions warrant.